For citations:
Smirnov V.A., Talypov A.E., Morozova Ya.V., Radaev S.M., Ryabov S.I., Zvyagintseva M.A., Bazanovich S.A., Grin A.A. Financial and economic rationale for using emerging cell therapy technologies for treatment of traumatic injuries of the central nervous system in high technology healthcare. Russian journal of neurosurgery. 2023;25(4):104-113. (In Russ.) https://doi.org/10.17650/1683-3295-2023-25-4-104-113
Email this article 